Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia
Abstract Worldwide, thyroid cancer accounts for some 10% of total cancer incidence, most markedly for females. Thyroid cancer radiotherapy, typically using 131I (T1/2 8.02 days; β− max energy 606 keV, branching ratio 89.9%), is widely adopted as an adjunct to surgery or to treat inoperable cancer an...
Guardado en:
Autores principales: | H. I. Al-Mohammed, A. Sulieman, Fareed H. Mayhoub, Hassan Salah, Celestino Lagarde, M. Alkhorayef, Ali Aldhebaib, C. Kappas, D. A. Bradley |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53d14499c8984c2ab7ded3ab28ce9a00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oxidative stress and radioiodine treatment of differentiated thyroid cancer
por: Angelika Buczyńska, et al.
Publicado: (2021) -
Epidemiology of tuberculosis among different occupational groups in Makkah region, Saudi Arabia
por: Hasan M. Semilan, et al.
Publicado: (2021) -
Real-time quantitation of thyroidal radioiodine uptake in thyroid disease with monitoring by a collar detection device
por: Prasanna Santhanam, et al.
Publicado: (2021) -
Jihad in Saudi Arabia
por: Sadek Hamid
Publicado: (2011) -
Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
por: Ruiguo Zhang, et al.
Publicado: (2017)